New LAT1 inhibitor can boost cancer treatment
Researchers at the University of Eastern Finland have developed a new and promising drug compound for the treatment of cancer that inhibits natural amino acids from entering cancer cells. Since amino acids are essential for the growth and division of cancer cells, the new LAT1 inhibitor makes it possible to inhibit their growth. The study was published in the journal Apoptosis. Many research groups around the world are studying the transport of amino acids into cancer cells, and inhibiting that transport, as a potential treatment for cancer. Adjunct Professor Kristiina Huttunen’s